Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 5 studies | 44% ± 21% | |
adipocyte | 3 studies | 19% ± 4% | |
GABAergic neuron | 3 studies | 43% ± 14% | |
interneuron | 3 studies | 31% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 40% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1207.02 | 245 / 245 | 85% | 4.23 | 426 / 502 |
kidney | 100% | 511.06 | 89 / 89 | 85% | 12.46 | 764 / 901 |
brain | 89% | 194.22 | 2355 / 2642 | 63% | 2.89 | 445 / 705 |
uterus | 85% | 265.43 | 144 / 170 | 49% | 3.22 | 226 / 459 |
breast | 91% | 175.92 | 419 / 459 | 41% | 1.00 | 455 / 1118 |
bladder | 100% | 374.67 | 21 / 21 | 22% | 0.74 | 113 / 504 |
esophagus | 62% | 70.18 | 889 / 1445 | 61% | 2.39 | 111 / 183 |
ovary | 68% | 76.50 | 123 / 180 | 52% | 1.75 | 224 / 430 |
skin | 100% | 314.54 | 1807 / 1809 | 18% | 0.65 | 84 / 472 |
stomach | 81% | 86.20 | 290 / 359 | 31% | 0.78 | 89 / 286 |
thymus | 73% | 58.46 | 474 / 653 | 21% | 0.89 | 129 / 605 |
blood vessel | 91% | 136.94 | 1219 / 1335 | 0% | 0 | 0 / 0 |
adipose | 87% | 133.84 | 1051 / 1204 | 0% | 0 | 0 / 0 |
intestine | 54% | 46.59 | 522 / 966 | 21% | 0.47 | 113 / 527 |
eye | 0% | 0 | 0 / 0 | 75% | 7.31 | 60 / 80 |
heart | 48% | 62.26 | 414 / 861 | 0% | 0 | 0 / 0 |
lung | 25% | 16.61 | 145 / 578 | 23% | 0.68 | 263 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 38% | 1.11 | 17 / 45 |
pancreas | 0% | 0.12 | 1 / 328 | 33% | 0.81 | 58 / 178 |
spleen | 29% | 26.28 | 70 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 7% | 3.86 | 19 / 258 | 7% | 0.21 | 16 / 230 |
liver | 1% | 0.52 | 2 / 226 | 2% | 0.08 | 8 / 406 |
muscle | 1% | 0.82 | 12 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.24 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030154 | Biological process | cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | GLIS1 |
Protein name | Zinc finger protein GLIS1 (GLI-similar 1) GLIS family zinc finger 1 |
Synonyms | |
Description | FUNCTION: Acts both as a repressor and an activator of transcription . Binds to the consensus sequence 5'-GACCACCCAC-3' (By similarity). By controlling the expression of genes involved in cell differentiation inhibits the lineage commitment of multipotent cells . Prevents, for instance, the differentiation of multipotent mesenchymal cells into adipocyte and osteoblast (By similarity). . |
Accessions | Q8NBF1 ENST00000312233.4 ENST00000628545.2 A0A0D9SEX9 |